BioCentury | Mar 15, 2021
Deals

Roche ramps up fast-growing infectious Dx segment with $1.8B takeout of GenMark

...pharma is adding to its infectious diseases diagnostics portfolio with the $1.8 billion acquisition of GenMark Diagnostics Inc....
...of deals.The companies expect the deal to close in the second quarter. Stephen Hansen EPlex Respiratory Pathogen Panel Roche GenMark Diagnostics Inc. bee2021 covid-19...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...appointed John Chisholm as non-executive chairman. He was chairman of Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. Vaxcyte...
BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

...an Emergency Use Authorization (EUA) to two additional PCR-based tests: the ePlex SARS-CoV-2 test from GenMark Diagnostics Inc....
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...2017-18 served as director of pharmaceutical sciences at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). GenMark Diagnostics Inc....
...as CEO. He was president and CEO of Symphony Health Solutions. BioCentury Staff Millendo Therapeutics Inc. Enterprise Therapeutics Ltd. GenMark Diagnostics Inc. Vividion...
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

...Therapeutics Inc. (NASDAQ:SAGE) 28% $125.10 TherapeuticsMD Inc. (NASDAQ:TXMD) 24% $5.15 3SBio Inc. (HKEX:1530) 21% HK$11.04 GenMark Diagnostics Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

...increased nearly eightfold in value to $2 billion since completing its IPO on Jan. 25. GenMark Diagnostics Inc....
...Food and Drug Administration, Beijing, China Five Prime Therapeutics Inc. (NASDAQ:FPRX), South San Francisco, Calif. GenMark Diagnostics Inc....
...Editor, Research & Analytics Ampion ANB020 cabiralizumab CART-BCMA laquinimod LCAR-B38M Mongersen Opdivo PARP inhibior Yescarta Zejula Active Biotech AB Ampio Pharmaceuticals Inc. AnaptysBio Inc. BGI Genomics Co. Ltd. Five Prime Therapeutics Inc. GenMark Diagnostics Inc. Gilead...
BioCentury | Jul 7, 2017
Finance

Generalists needed

...OTCQX:PFSCF) 6/15/17 $39.5 $881.9 $887.2 1% Loxo Oncology Inc. (NASDAQ:LOXO) 6/14/17 $260.8 $2,143.6 $2,387.5 11% GenMark Diagnostics Inc....
BioCentury | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

...On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4...
...JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James. GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Jaime De Leon GenMark Diagnostics Inc....
BioCentury | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

...Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at...
...Fungal Pathogen Panel eSensor 2C19 Genotyping Test eSensor Cystic Fibrosis Genotyping Test eSensor Respiratory Virus Panel eSensor Thrombophilia Risk Test GenMark Diagnostics Inc....
BioCentury | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

...platform. GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Product: ePlex Blood Culture Identification Fungal Pathogen Panel Business: Diagnostic Julian Zhu GenMark Diagnostics Inc. ePlex...
Items per page:
1 - 10 of 61
BioCentury | Mar 15, 2021
Deals

Roche ramps up fast-growing infectious Dx segment with $1.8B takeout of GenMark

...pharma is adding to its infectious diseases diagnostics portfolio with the $1.8 billion acquisition of GenMark Diagnostics Inc....
...of deals.The companies expect the deal to close in the second quarter. Stephen Hansen EPlex Respiratory Pathogen Panel Roche GenMark Diagnostics Inc. bee2021 covid-19...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...appointed John Chisholm as non-executive chairman. He was chairman of Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. Vaxcyte...
BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

...an Emergency Use Authorization (EUA) to two additional PCR-based tests: the ePlex SARS-CoV-2 test from GenMark Diagnostics Inc....
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...2017-18 served as director of pharmaceutical sciences at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA). GenMark Diagnostics Inc....
...as CEO. He was president and CEO of Symphony Health Solutions. BioCentury Staff Millendo Therapeutics Inc. Enterprise Therapeutics Ltd. GenMark Diagnostics Inc. Vividion...
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

...Therapeutics Inc. (NASDAQ:SAGE) 28% $125.10 TherapeuticsMD Inc. (NASDAQ:TXMD) 24% $5.15 3SBio Inc. (HKEX:1530) 21% HK$11.04 GenMark Diagnostics Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

...increased nearly eightfold in value to $2 billion since completing its IPO on Jan. 25. GenMark Diagnostics Inc....
...Food and Drug Administration, Beijing, China Five Prime Therapeutics Inc. (NASDAQ:FPRX), South San Francisco, Calif. GenMark Diagnostics Inc....
...Editor, Research & Analytics Ampion ANB020 cabiralizumab CART-BCMA laquinimod LCAR-B38M Mongersen Opdivo PARP inhibior Yescarta Zejula Active Biotech AB Ampio Pharmaceuticals Inc. AnaptysBio Inc. BGI Genomics Co. Ltd. Five Prime Therapeutics Inc. GenMark Diagnostics Inc. Gilead...
BioCentury | Jul 7, 2017
Finance

Generalists needed

...OTCQX:PFSCF) 6/15/17 $39.5 $881.9 $887.2 1% Loxo Oncology Inc. (NASDAQ:LOXO) 6/14/17 $260.8 $2,143.6 $2,387.5 11% GenMark Diagnostics Inc....
BioCentury | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

...On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4...
...JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James. GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Jaime De Leon GenMark Diagnostics Inc....
BioCentury | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

...Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at...
...Fungal Pathogen Panel eSensor 2C19 Genotyping Test eSensor Cystic Fibrosis Genotyping Test eSensor Respiratory Virus Panel eSensor Thrombophilia Risk Test GenMark Diagnostics Inc....
BioCentury | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

...platform. GenMark Diagnostics Inc. (NASDAQ:GNMK), Carlsbad, Calif. Product: ePlex Blood Culture Identification Fungal Pathogen Panel Business: Diagnostic Julian Zhu GenMark Diagnostics Inc. ePlex...
Items per page:
1 - 10 of 61